Recombinant human bone morphogenetic protein-2 (rhBMP-2) in the treatment of mandibular sequelae after tumor resection

Oral and Maxillofacial Surgery

Volumn 15, Issue 3, 2011, Pages 169-174

  Zetola A ^a   Ferreira, Felipe Mussi ^b   Larson, Rafaela ^c   Shibli, Jamil Awad ^d  

^a Oral Implantology   (Brazil)

^b Bauru Hospital   (Brazil)

^c Paraná University   (Brazil)

^d GUARULHOS UNIVERSITY   (Brazil)

Author keywords

Ameloblastoma; Bone morphogenetic protein; Cysts

Indexed keywords

BIOMATERIAL; BONE MORPHOGENETIC PROTEIN 2; CALCIUM PHOSPHATE; COLLAGEN; DRUG CARRIER; HYDROXYAPATITE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AMELOBLASTOMA; ARTICLE; BONE PLATE; BONE PROSTHESIS; BONE TRANSPLANTATION; CASE REPORT; DEVICE REMOVAL; EQUIPMENT; FEMALE; FOLLOW UP; HUMAN; MANDIBLE TUMOR; METHODOLOGY; MOUTH DISEASE; PLASTIC SURGERY; SKIN FISTULA; SURGICAL EQUIPMENT; SURGICAL INFECTION; WOUND DEHISCENCE;

ADULT; AMELOBLASTOMA; BIOCOMPATIBLE MATERIALS; BONE MORPHOGENETIC PROTEIN 2; BONE PLATES; BONE SUBSTITUTES; BONE TRANSPLANTATION; CALCIUM PHOSPHATES; COLLAGEN; CUTANEOUS FISTULA; DEVICE REMOVAL; DRUG CARRIERS; DURAPATITE; EQUIPMENT FAILURE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MANDIBULAR NEOPLASMS; ORAL FISTULA; RECOMBINANT PROTEINS; RECONSTRUCTIVE SURGICAL PROCEDURES; SURGICAL MESH; SURGICAL WOUND DEHISCENCE; SURGICAL WOUND INFECTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 80051819814     PISSN: 18651550     EISSN: 18651569     Source Type: Journal    
DOI: 10.1007/s10006-010-0236-7     Document Type: Article

References (20)

1. Becelli R, Carboni A, Cerulli G, Perugini M, Iannetti G (2002) Mandibular ameloblastoma: analysis of surgical treatment carried out in 60 patients between 1977 and 1998. J Craniofac Surg 13: 395.
2. Fletcher CDM (2007) Diagnostic histopathology of tumors, 3rd edn. Churchill Livingstone, Philadelphia.
3. Vayvada H, Mola F, Menderes A, Yilmaz M (2006) Surgical management of ameloblastoma in the mandible: segmental mandibulectomy and immediate reconstruction with free fibula or deep circumflex iliac artery flap: evaluation of the long-term esthetic and functional results. J Oral Maxillofac Surg 64: 1532.
4. Bataineh A, Jordan I (2000) Effect of preservation of the inferior borders on recurrence of ameloblastomas of the mandible. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 90: 155.
5. Carter TG, Brar PS, Tolas A, Beirne OR (2008) Off-label use of recombinant human bone morphogenetic protein-2 (rhBMP-2) for reconstruction of mandibular bone defects in humans. J Oral Maxillofac Surg 66: 1417.
6. Herford AS, Boyne PJ (2008) Reconstruction of mandibular continuity defects with bone morphogenetic protein-2 (rhBMP-2). J Oral Maxillofac Surg 66: 616.
7. Schuckert KH, Jopp S, Teoh SH (2009) Mandibular defect reconstruction using three-dimensional polycaprolactone scaffold in combination with platelet-rich plasma and recombinant human bone morphogenetic protein-2: de novo synthesis of bone in a single case. Tissue Eng A 15: 493.
8. Visser R, Arrabal PM, Becerra J, Rinas U, Cifuentes M (2009) The effect of an rhBMP-2 absorbable collagen sponge-targeted system on bone formation in vivo. Biomaterials 30: 2032.
9. Ferreira GR, Cestari TM, Granjeiro JM, Taga R (2004) Lack of repair of rat skull critical size defect treated with bovine morphometric protein bound to microgranular bioabsorbable hydroxyapatite. Braz Dent J 15: 175.
10. Toriumi DM, Kotler HS, Luxenberg DP et al (2001) Mandibular reconstruction with a recombinant bone inducing factor. Arch Otolaryngol Head Neck Surg 117: 1101.
11. Tolman DE (1995) Reconstructive procedures with endosseous implants in grafted bone: a review of the literature. Int J Oral Maxillofac Implants 10: 275.
12. Yoneda M, Terai H, Imai Y, Okada T, Nozaki K, Inoue H, Miyamoto S, Takaoka K (2005) Repair of an intercalated long bone defect with a synthetic biodegradable bone-inducing implant. Biomaterials 26: 5145.
13. Moore WR, Graves SE (2001) Bain GI: synthetic bone graft substitutes. ANZ J Surg 71: 354.
14. Boyne PJ, Marx RE, Nevins M, Triplett G, Lazaro E, Lilly LC, Alder M, Nummikoski P (1997) A feasibility study evaluating rhBMP2 /absorbable collagen sponge for maxillary sinus floor augmentation. Int J Periodontics Restor Dent 17: 11.
15. Howell TH, Fiorellini J, Jones A, Alder M, Nummikoski P, Lazaro M, Lilly L, Cochran D (1997) A feasibility study evaluating rhBMP-2/absorbable collagen sponge device for local alveolar ridge preservation or augmentation. Int J Periodont Rest Dent 17: 124-139.
16. Lutolf MP, Weber FE, Schmoekel HG, Schense JC, Kohler T, Muller R, Hubbell JA (2003) Repair of bone defects using synthetic mimetics of collagenous extracellular matrices. Nat Biotechnol 21: 513-518.
17. Mangano C, Piattelli A, Mangano F et al (2009) Combining scaffolds and osteogenic cells in regenerative bone surgery: a preliminary histological report in human maxillary sinus augmentation. Clin Implant Dent Relat Res Suppl 1: e92.
18. Barboza EP, Duarte MEL, Geolas L, Sorensen RG, Riedel GE, Wikesjö UME (2000) Ridge augmentation following implantation of recombinant human bone morphogenetic protein-2 in the dog. J Periodontol 71: 488.
19. Arosarena OA, Collins WL (2005) Bone regeneration in the rat mandible with bone morphogenetic protein-2: a comparison of two carriers. Otolaryngol Head Neck Surg 132: 592.
20. Miranda DA, Blumenthal NM, Sorensen RG, Wozney JM, Wikesjö UM (2005) Evaluation of recombinant human bone morphogenetic protein-2 on the repair of alveolar ridge defects in baboons. J Periodontol 76: 210.